Luminal breast cancer is further divided into Luminal A (ER+, PR+/−, HER2-, Ki67 ≤ 14–20%)) and Luminal B (ER+/−, PR+/−, HER2+, or Ki67 > 14–20%). This evidence concerns the gene ERBB2 and breast cancer.